Learn firsthand about research, funded by donations, being done to find a treatment for Multiple System Atrophy. This is the final webinar of four in the 2022 webinar series “From Bench to Bedside: The Promise and Hope of MSA Research.” This series has highlighted researchers who applied for and won a grant from the Coalition’s seed grant program. In 2022 over $500,000 was invested in new research projects with total invested to date of over $3 million since the program's inception in 2013.

For this final webinar, we welcomed Dr. Roy Freeman, Professor of Neurology at Harvard Medical School and the Director of the Center for Autonomic and Peripheral Nerve Disorders at Beth Israel Deaconess Medical Center. He presented on his research topic "A Cutaneous Diagnostic Biomarker for MSA."

THIS EDUCATIONAL SESSION IS NOT INTENDED FOR THE PURPOSE OF PROVIDING MEDICAL ADVICE. All information, content, and material is for informational purposes only and are not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. The information supplied through webinars or on our webpage, or by any representative or agent of the MSA Coalition, whether by telephone, email, letter, or other form of communication, is for informational purposes only and does not constitute medical, legal or other professional advice.